Biologic Manufacturing World Asia 2010

March 16 - 19, 2010(Ended)

Raffles City Convention Centre
Singapore

Biologic Manufacturing World Asia will bring together international and regional biopharmaceutical manufacturers, small biotechs, academic institutions, contract manufacturing service and technology providers to discuss trends, best offshoring, outsourcing and operational strategies for biologic manufacturing, methodologies and technologies to improve productivity, quality, efficiency and profitability.

Biologic Manufacturing World Asia will be hosting a joint exhibition with Pharma R&D Partnering World Asia, Drug Discovery Technology World Asia, World Pharma Trials Asia as well as Pharma & Biotech Supply Chain Asia at Raffles City Convention Centre.

The biologics market is expected to grow by 11.6% in the next 5 years while small molecule drugs forecasted to grow are single-digit rates. The economic slowdown has also brought about a year of consolidation with Pfizer buying up Wyeth, Merck buying Schering-Plough and Roche buying the part of Genentech which it did not own. It was said that major reasons of the M&A deals were done to access and harness technology platforms as well as commercialize products to the market.

Big and small biopharmaceutical manufacturers are gearing up for growth in the biologics sector with announcements of expansion and mergers taking place around the globe where it has become increasing important for manufacturers to become ‘smarter’ in their manufacturing and operations strategy to save costs and ‘go green’ at the same time.

Venue

Raffles City Convention Centre

Address

80 Bras Basah Road, 189560 ,
Singapore

Prices *

3055 Singapore Dollar

Exhibition

Included

Organization

Terrapinn

Website

www.terrapinn.com/2010/biologicasia